# Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer

> **NCT02220062** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 166 (estimated)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **PROCEDURE:** EUS-CPN
- **PROCEDURE:** EUS-CGN

## Key facts

- **NCT ID:** NCT02220062
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2016-08
- **Final completion:** —
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2014-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220062, "Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain Killer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02220062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*